Prescription Digital Therapeutics

PilLow RX

PilLow addresses the underlying cause of chronic insomnia by guiding patients to modify their thought processes and behavior for better sleep. PilLow's underlying mechanism, Cognitive Behavioral Therapy for Insomnia (CBT-i), is the guideline-recommended first-line therapy for insomnia.


Insomnia in Korea

Group 8008.png

Source: Health Insurance Review & Assessment Service

Source: OECD

Group 8009.png

Source: Health Insurance Review & Assessment Service
Korean Sleep Research Society

The unmet needs of insomnia

Group 8011.png

Sleep medications are only
recommended for short term use
and may have unwanted side-effects

Sleeping pills help induce
and maintain sleep, but do
not solve the underyling cause.

Group 8010.png

Limited access to first-line treatment:
Cognitive Behavioral Therapy (CBT)

Limited number of CBTi
accredited providers

What is CBT-I ?

CBT-I (I for Insomnia) coaches patients to identify feelings, thoughts and behaviors that are contributing to the symptoms of insomnia and helps reframe any misconceptions for better sleep.

Why CBT-I ?

The American College of Physicians recommends CBT-I as the first-line treatment 
for all adults with chronic insomnia. Because CBT-I is noninvasive, it is likely to have fewer harms, whereas sleeping pills can be associated with serious adverse events.
It is also known to have better long term efficacy over pharmacotherapy. With more than 20 years of research, CBT-I has become the gold standard of insomnia care.

Changes in Sleep Efficiency, %

Group 7905.png

Changes in Sleep Latency, %

Group 7904.png

source: Jacobs, Gregg D., et al. (2004)